Literature DB >> 15731376

Dynamic contrast-enhanced MR imaging kinetic parameters and molecular weight of dendritic contrast agents in tumor angiogenesis in mice.

Quido G de Lussanet1, Sander Langereis, Regina G H Beets-Tan, Marcel H P van Genderen, Arjan W Griffioen, Jos M A van Engelshoven, Walter H Backes.   

Abstract

PURPOSE: To evaluate the relationship between dynamic contrast agent-enhanced magnetic resonance (MR) imaging-derived kinetic parameters and contrast agents of equal chemical composition and configuration but with different molecular weights in a tumor angiogenesis model.
MATERIALS AND METHODS: This study was approved by the ethical review committee. Maintenance and care of animals was in compliance with guidelines set by the institutional animal care committee. Dynamic contrast-enhanced MR imaging was performed with dendritic contrast agents in 16 mice with tumor xenografts; mice were placed in groups of four for each molecular weight of the contrast agent. The magnitude and spatial distribution of kinetic parameters (transfer coefficient [K(PS)] and plasma fraction [f(PV)]) were compared with molecular weight of the contrast agent by determining the Spearman correlation coefficient (r) and the quantitative relationship between the endothelial K(PS) and molecular weight.
RESULTS: Inverse relationships between molecular weight of contrast agent and K(PS) and f(PV) of tumor rim (r = -0.8, P < .001 and r = -0.5, P = .04, respectively) and core (r = -0.7, P = .004 and r = -0.6, P = .01, respectively) were observed. The quantitative relationship between K(PS) and molecular weight (MW) was K(PS) = 0.4/MW(0.44). A decreasing stepwise pattern in f(PV) was noted between contrast agents with low (0.7- and 3.0-kDa) molecular weight and those with high (12- and 51-kDa) molecular weight.
CONCLUSION: Macromolecular permeability is best measured with high-molecular-weight contrast agents; endothelial K(PS) values measured with low-molecular-weight contrast agents incorporate tissue perfusion and permeability and demonstrate heterogeneous microcirculatory flow. (c) RSNA, 2005.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15731376     DOI: 10.1148/radiol.2351040411

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  29 in total

1.  Vascular endothelial growth factor antisense oligonucleotides inhibit leptomeningeal metastasis in vivo.

Authors:  Kangan Li; Guixiang Zhang; Jinglong Zhao; Xifu Wang; Yujie Li; Yunsheng Hu
Journal:  Med Oncol       Date:  2010-05-26       Impact factor: 3.064

2.  Evaluation of neovessels in atherosclerotic plaques of rabbits using an albumin-binding intravascular contrast agent and MRI.

Authors:  Jean-Christophe Cornily; Fabien Hyafil; Claudia Calcagno; Karen C Briley-Saebo; James Tunstead; Juan-Gilberto S Aguinaldo; Venkatesh Mani; Vito Lorusso; Friedrich M Cavagna; Zahi A Fayad
Journal:  J Magn Reson Imaging       Date:  2008-06       Impact factor: 4.813

3.  Pixel-based absorption correction for dual-tracer fluorescence imaging of receptor binding potential.

Authors:  Stephen C Kanick; Kenneth M Tichauer; Jason Gunn; Kimberley S Samkoe; Brian W Pogue
Journal:  Biomed Opt Express       Date:  2014-08-29       Impact factor: 3.732

4.  Correcting for targeted and control agent signal differences in paired-agent molecular imaging of cancer cell-surface receptors.

Authors:  Negar Sadeghipour; Scott C Davis; Kenneth M Tichauer
Journal:  J Biomed Opt       Date:  2018-06       Impact factor: 3.170

5.  Task-based evaluation of fluorescent-guided cancer surgery as a means of identifying optimal imaging agent properties in the context of variability in tumor- and healthy-tissue physiology.

Authors:  Kenneth M Tichauer; Cheng Wang; Xiaochun Xu; Kimberley S Samkoe
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2020-02-19

6.  Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model.

Authors:  Moira C Ferrier; Hemant Sarin; Steve H Fung; Bawarjan Schatlo; Ryszard M Pluta; Sandeep N Gupta; Peter L Choyke; Edward H Oldfield; David Thomasson; John A Butman
Journal:  Neoplasia       Date:  2007-07       Impact factor: 5.715

7.  Tumor endothelial marker imaging in melanomas using dual-tracer fluorescence molecular imaging.

Authors:  Kenneth M Tichauer; Sophie J Deharvengt; Kimberley S Samkoe; Jason R Gunn; Marcus W Bosenberg; Mary-Jo Turk; Tayyaba Hasan; Radu V Stan; Brian W Pogue
Journal:  Mol Imaging Biol       Date:  2013-11-12       Impact factor: 3.488

8.  Noninvasive evaluation of antiangiogenic effect in a mouse tumor model by DCE-MRI with Gd-DTPA cystamine copolymers.

Authors:  Xueming Wu; Eun-Kee Jeong; Lyska Emerson; John Hoffman; Dennis L Parker; Zheng-Rong Lu
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

9.  Quantitative estimation of permeability surface-area product in astroglial brain tumors using perfusion CT and correlation with histopathologic grade.

Authors:  R Jain; S K Ellika; L Scarpace; L R Schultz; J P Rock; J Gutierrez; S C Patel; J Ewing; T Mikkelsen
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-17       Impact factor: 3.825

10.  The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment.

Authors:  Bariş Türkbey; David Thomasson; Yuxi Pang; Marcelino Bernardo; Peter L Choyke
Journal:  Diagn Interv Radiol       Date:  2009-11-02       Impact factor: 2.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.